Abeona Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Abeona Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 148% to $3,500,000. Profit margin reached -1548%. Total operating expenses were $49,030,000.
Profit Margin
| 2014 | 925K | -26.77M | -2894.92% |
|---|---|---|---|
| 2015 | 1.04M | -14.52M | -1396.73% |
| 2016 | 889K | -21.87M | -2460.4% |
| 2017 | 837K | -27.31M | -3263.92% |
| 2018 | 2.99M | -56.67M | -1890.29% |
| 2019 | 0 | -76.68M | |
| 2020 | 10M | -88.34M | -883.49% |
| 2021 | 3M | -88.60M | -2953.53% |
| 2022 | 1.41M | -31.80M | -2249.58% |
| 2023 | 3.5M | -54.18M | -1548.23% |
ABEO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 3.5M | 1.41M | 3M | 10M | 0 | 2.99M | 837K | 889K | 1.04M | 925K |
Cost of revenue | 1.60M | 450K | 4.46M | 30.13M | 8.67M | 0 | 16.98M | 0 | 0 | 0 |
Gross profit | 1.89M | 964K | -1.46M | -20.13M | -8.67M | 2.99M | -16.15M | 889K | 1.04M | 925K |
Operating exp. | ||||||||||
Research and development | 31.09M | 28.96M | 34.32M | 30.13M | 48.56M | 38.69M | 16.98M | 10.65M | 4.71M | 333K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 49.03M | 46.22M | 60.37M | 58.50M | 77.09M | 61.16M | 28.67M | 24.77M | 19.58M | 4.05M |
Operating income | -47.13M | -45.25M | -89.83M | -81.42M | -77.09M | -58.16M | -27.83M | -23.88M | -18.54M | -3.13M |
Other income (expenses), net | -7.05M | 5.56M | 4.9M | -2.81M | 808K | 1.49M | 517K | 2.00M | 4.02M | -23.64M |
Income before tax | -54.18M | -39.69M | -84.93M | -84.23M | -76.28M | -56.67M | -27.31M | -21.87M | -14.52M | -26.77M |
Income tax expense | 0 | -7.88M | 3.67M | 4.11M | 400K | 1.50M | 525K | 2.01M | 4.02M | 582K |
Net income | -54.18M | -31.80M | -88.60M | -88.34M | -76.68M | -56.67M | -27.31M | -21.87M | -14.52M | -26.77M |
Earnings per share | ||||||||||
Basic EPS | -2.53 | -4.05 | -22.5 | -23.84 | -38.07 | -29.81 | -16.4 | -16 | -13.16 | -344.56 |
Diluted EPS | -2.53 | -4.05 | -22.5 | -23.84 | -38.07 | -29.81 | -16.4 | -16 | -13.16 | -344.56 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |